Literature DB >> 23617874

Association between craving and attention deficit/hyperactivity disorder symptoms among patients with alcohol use disorders.

Andrea Seitz1, Manuela Wapp, Yuliya Burren, Sonja Stutz, Katrin Schläfli, Franz Moggi.   

Abstract

BACKGROUND/AIM: Adult Alcohol Use Disorders (AUD) patients with Attention Deficit/Hyperactivity Disorder (ADHD) symptoms may suffer more from craving than patients who only have AUD. However, craving may be even more strongly related to withdrawal and psychiatric symptoms; therefore, the association between craving and ADHD may be misinterpreted. The purpose of this study is to examine the association between craving and ADHD symptoms among AUD patients in more detail.
METHODS: In a multisite study, 385 patients with and without ADHD symptoms who were attending treatment for alcohol dependence were compared in terms of craving, withdrawal, and psychiatric symptoms. The contribution of ADHD symptoms to craving was estimated in a hierarchical regression analysis by controlling for psychiatric and withdrawal symptoms.
RESULTS: Patients with probable adult ADHD showed higher craving, more withdrawal and psychiatric symptoms, and rated withdrawal symptoms as more severe than did patients without ADHD symptoms. In the regression model, only about 3% of variance in alcohol craving was explained by ADHD symptomatology, whereas 23% of the variance was explained when withdrawal and psychiatric symptoms were added to the model.
CONCLUSIONS: Alcohol craving is likely related to withdrawal and psychiatric symptoms more strongly than to ADHD symptoms.
Copyright © American Academy of Addiction Psychiatry.

Entities:  

Mesh:

Year:  2013        PMID: 23617874     DOI: 10.1111/j.1521-0391.2012.12000.x

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  1 in total

Review 1.  [ADHD in adult patients with substance use disorders].

Authors:  Mathias Luderer; Falk Kiefer; Andreas Reif; Franz Moggi
Journal:  Nervenarzt       Date:  2019-09       Impact factor: 1.214

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.